Use of r-(+)-.alpha.-lipoic acid, r-(-)-dihydrolipoic acid...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/385 (2006.01) A61K 38/28 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2138558

The invention relates to the use of R-(+)-.alpha.-lipoic acid, R-(-)-dihydrolipoic acid or their metabolites, salts, esters and amides for the synthesis of drugs for the treatment of diabetes mellitus of types I and II, compensated and decompensated insulin resistance and sequelae or late complications of diabetes mellitus, such as cataracts, polyneuropathy, nephropathy, as well as sequelae or late complications of insulin resistance. These drugs mentioned can also be used advantageously in combination with other antidiabetic drugs, particularly with insulin, and/or other additives or stabilizers or adjuvants, such as vitamin E, vitamin C, NADH, NADPH and ubiquinone. The invention furthermore relates to the use of R-(+)-.alpha.-lipoic acid, R-(-)--dihydrolipoic acid or their metabolites, as well as their salts, esters and amides for the preparation of drugs for the treatment of diseases with limited function of or a lowered content of the glucose transporters.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of r-(+)-.alpha.-lipoic acid, r-(-)-dihydrolipoic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of r-(+)-.alpha.-lipoic acid, r-(-)-dihydrolipoic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of r-(+)-.alpha.-lipoic acid, r-(-)-dihydrolipoic acid... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1677809

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.